Cargando…

Exogenous Control of the Expression of Group I CD1 Molecules Competent for Presentation of Microbial Nonpeptide Antigens to Human T Lymphocytes

Group I CD1 (CD1a, CD1b, and CD1c) glycoproteins expressed on immature and mature dendritic cells present nonpeptide antigens (i.e., lipid or glycolipid molecules mainly of microbial origin) to T cells. Cytotoxic CD1-restricted T lymphocytes recognizing mycobacterial lipid antigens were found in tub...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aquino, Angelo, Graziani, Grazia, Franzese, Ornella, Prete, Salvatore P., Bonmassar, Enzo, Bonmassar, Laura, D'Atri, Stefania
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095450/ https://www.ncbi.nlm.nih.gov/pubmed/21603161 http://dx.doi.org/10.1155/2011/790460

Ejemplares similares

Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors
por: Franzese, Ornella, et al.
Publicado: (2017)

The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro
por: Adamo, Riccardo, et al.
Publicado: (2013)

NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug
por: Caporali, Simona, et al.
Publicado: (2012)

Defect in HSP90 expression in highly differentiated human CD8(+) T lymphocytes
por: Franzese, O, et al.
Publicado: (2014)

Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?
por: Franzese, Ornella, et al.
Publicado: (2021)

Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway
por: Caporali, Simona, et al.
Publicado: (2015)

Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints
por: Franzese, Ornella, et al.
Publicado: (2022)

Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor
por: Giorgioni, Gianfabio, et al.
Publicado: (2022)

Combined effects of 5-Fluorouracil, Folinic acid and Oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy
por: Prete, Salvatore P, et al.
Publicado: (2008)

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib
por: Caporali, Simona, et al.
Publicado: (2017)

Targeting Staphylococcus aureus Quorum Sensing with Nonpeptidic Small Molecule Inhibitors
por: Murray, Ewan J., et al.
Publicado: (2014)

miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
por: Caporali, Simona, et al.
Publicado: (2019)

Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures
por: Merlino, Francesco, et al.
Publicado: (2013)

Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab
por: Narducci, Maria Grazia, et al.
Publicado: (2020)

Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy
por: Levati, Lauretta, et al.
Publicado: (2022)

Inflammatory Microenvironment and Adipogenic Differentiation in Obesity: The Inhibitory Effect of Theobromine in a Model of Human Obesity In Vitro
por: Fuggetta, Maria Pia, et al.
Publicado: (2019)

MRI-Induced Heating of Coils for Microscopic Magnetic Stimulation at 1.5 Tesla: An Initial Study
por: Bonmassar, Giorgio, et al.
Publicado: (2020)

Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1
por: Ruffini, Federica, et al.
Publicado: (2017)

Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma
por: Ruffini, Federica, et al.
Publicado: (2015)

Nonpeptide Small Molecule Agonist and Antagonist Original Leads for Neuropeptide FF1 and FF2 Receptors
por: Journigan, V. Blair, et al.
Publicado: (2014)

The impact of novelty and emotion on attention-related neuronal and pupil responses in children
por: Bonmassar, Carolina, et al.
Publicado: (2020)

Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferon.
por: D'Onofrio, C., et al.
Publicado: (1988)

Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response
por: Aquino, Angelo, et al.
Publicado: (2023)

PTFOS: Flexible and Absorbable Intracranial Electrodes for Magnetic Resonance Imaging
por: Bonmassar, Giorgio, et al.
Publicado: (2012)

A tutorial on the use of temporal principal component analysis in developmental ERP research – Opportunities and challenges
por: Scharf, Florian, et al.
Publicado: (2022)

Short-pulsed micro-magnetic stimulation of the vagus nerve
por: Jeong, Hongbae, et al.
Publicado: (2022)

Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib
por: Atzori, Maria Grazia, et al.
Publicado: (2019)

Functional Inactivation in the Whole Population of Human Vγ9/Vδ2 T Lymphocytes Induced By a Nonpeptidic Antagonist
por: Bürk, Martin R., et al.
Publicado: (1997)

Influence of Polydatin on the Tumor Microenvironment In Vitro: Studies with a Colon Cancer Cell Model
por: De Gregorio, Alex, et al.
Publicado: (2022)

Multiple oscillatory rhythms determine the temporal organization of perception
por: Ronconi, Luca, et al.
Publicado: (2017)

Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist
por: Erickson-Miller, Connie L, et al.
Publicado: (2009)

Pharmacophore Modeling and Docking Studies on Some Nonpeptide-Based Caspase-3 Inhibitors
por: Sharma, Simant, et al.
Publicado: (2013)

A Nonpeptide Oxytocin Receptor Agonist for a Durable Relief of Inflammatory Pain
por: Hilfiger, Louis, et al.
Publicado: (2020)

Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity
por: Nevers, Quentin, et al.
Publicado: (2018)

Interfacing Sca-1(pos) Mesenchymal Stem Cells with Biocompatible Scaffolds with Different Chemical Composition and Geometry
por: Forte, G., et al.
Publicado: (2009)

Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding
por: Graziani, Grazia, et al.
Publicado: (2016)

A Novel Brain Stimulation Technology Provides Compatibility with MRI
por: Serano, Peter, et al.
Publicado: (2015)

Novel therapeutics for the treatment of hypertension and its associated complications: peptide- and nonpeptide-based strategies
por: Ghatage, Trupti, et al.
Publicado: (2021)

Major Histocompatibility Complex Class I Molecules Modulate Activation Threshold and Early Signaling of T Cell Antigen Receptor–γ/δ Stimulated by Nonpeptidic Ligands
por: Carena, Ilaria, et al.
Publicado: (1997)

Selection of HTLV-I positive clones is prevented by prostaglandin A in infected cord blood cultures.
por: D'Onofrio, C., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_d6rg4qgdvhkhg8s617h5nrc89u